AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Phathom Pharmaceuticals, Inc. Director's Dealing 2025

Apr 16, 2025

32407_dirs_2025-04-16_ad4ab9fb-adbf-49d4-b9e0-84edd139ced6.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Phathom Pharmaceuticals, Inc. (PHAT)
CIK: 0001783183
Period of Report: 2025-04-16

Reporting Person: Schroeder Theodore R (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities are beneficially owned.	0	Direct